Concepedia

Andrzej Dekundy

AD

Statistics

Publications

25

Citations

1.5K

H-Index

18

Active since

2001

Affiliations

MerLion Pharma (Germany)(Current)

Lund University

Instytut Medycyny Wsi im. Witolda Chodźki

Medical University of Lublin

University of Ferrara

Andrzej Dekundy is an author at MerLion Pharma (Germany) specializing in neuropharmacology, neuroscience, and pharmacology.

Publications per year

2001–2022

25

Publications

25

Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model

Andrzej Dekundy, Martin Lundblad, Wojciech Danysz et al. · Behavioural Brain Research · 2007 · 217 citations

Medicine, Neuroscience, Pharmacology +16

Antagonism of metabotropic glutamate receptor type 5 attenuates <scp>l</scp>‐DOPA‐induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson’s disease

F Mela, Matteo Marti, Andrzej Dekundy et al. · Journal of Neurochemistry · 2007 · 202 citations

Life Sciences, Neuroscience, Pharmacology +17

Pharmacological Modulation of Glutamate Transmission in a Rat Model of l-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling

Alessandra Recchia, F Mela, Andrzej Dekundy et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 170 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia

Christine Konradi, Jenny E. Westin, Manolo Carta et al. · Neurobiology of Disease · 2004 · 159 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys

Daniella Rylander Ottosson, Hanna Iderberg, Qin Li et al. · Neurobiology of Disease · 2010 · 151 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

1–5 of 25